Morphometric Brain abnormalities in schizophrenia in a population-based sample: Relationship to duration of illness

Schizophrenia Bulletin

Volumn 36, Issue 4, 2010, Pages 766-777

  Tanskanen, Päivikki ^a   Ridler, Khanum ^b,c   Graham K Murray, ^c   Haapea, Marianne ^a   Veijola, Juha M ^a,d   Jääskeläinen, Erika ^a   Miettunen, Jouko ^a   Jones, Peter B ^c   Bullmore, Edward T ^c   Isohanni, Matti K ^a  

^a UNIVERSITY OF OULU   (Finland)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ACADEMY OF FINLAND   (Finland)

Author keywords

Birth cohort; Gray matter; Magnetic resonance imaging; Schizophrenia; Voxel based morphometry; White matter

Indexed keywords

NEUROLEPTIC AGENT;

AGED; ARTICLE; BRAIN MALFORMATION; BRAIN REGION; CEREBROSPINAL FLUID; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; URINALYSIS; WHITE MATTER; ADULT; BRAIN; BRAIN VENTRICLE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FINLAND; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; MALE; NONPARAMETRIC TEST; ONSET AGE; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADULT; AGE OF ONSET; BRAIN; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID; COHORT STUDIES; DISEASE PROGRESSION; DOMINANCE, CEREBRAL; FEMALE; FINLAND; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; REFERENCE VALUES; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 77956499776     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn141     Document Type: Article

References (83)

1. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brainvolumes in schizophrenia. Am J Psychiatry. 2000;157:16-25.
2. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampalvolume reduction in schizophrenia as assessed bymagnetic resonance imaging. Arch Gen Psychiatry. 1998;55:433-440.
3. Shenton ME, Dickey CC, Frumin M, McCarley RW. A reviewof MRI findings in schizophrenia. Schizophr Res. 2001;49:1-52.
4. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia.A systematic and quantitative review of volumetric magneticresonance imaging studies. Br J Psychiatry. 1998;172:110-120.
5. Hulshoff Pol HE, Schnack HG, Mandl RCW, et al. Focalgray matter changes in schizophrenia. Arch Gen Psychiatry.2001;58:1118-1125.
6. Kubicki M, Shenton ME, Salisbury DF, et al. Voxel-basedmorphometric analysis of gray matter in first episode schizophrenia.Neuroimage. 2002;17:1711-1719.
7. Meda SA, Giuliani NR, Calhoun VD, et al. A large scale(N=400) investigation of gray matter differences in schizophreniausing optimized voxel-based morphometry. Schizophr Res. 2008;101:95-105.
8. Moorhead TWJ, Job DE, Whalley HC, Sanderson TL, Johnstone EC, Lawrie SM. Voxel-based morphometry of comorbid schizophrenia and learning disability: analysesin normalised and native spaces using parametric and nonparametricstatistical Methods. Neuroimage. 2004;22:188-202.
9. Sigmundsson T, Suckling J, Maier M, et al. Structural abnormalitiesin frontal, temporal, and limbic regions and interconnectingwhite matter tracts in schizophrenic patients withprominent negative symptoms. Am J Psychiatry. 2001;158:234-243.
10. Wilke M, Kaufman C, Grabner A, Pü tz B, Wetter TC, Auer DP. Gray matter-changes and correlates of disease severity inschizophrenia: a statistical parametric mapping study. Neuroimage.2001;13:814-824.
11. Honea R, Crow TJ, Passingham D, Mackay CE. Regionaldeficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry. 2005;162:2233-2245.
12. Smith GN, Iacono WG. Lateral ventricular size in schizophreniaand choice of control group. Lancet. 1986;1:1450.
13. Haapea M, Miettunen J, Veijola J, Lauronen E, TanskanenP, Isohanni M. Non-participation may bias the results of a psychiatric survey: an analysis from the survey includingmagnetic resonance imaging within the Northern Finland1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol.2007;42:403-409.
14. Jones PB, Harvey I, Lewis SW, et al. Cerebral ventricledimensions as risk factors for schizophrenia and affective psychosis.An epidemiological approach to analysis. PsycholMed. 1994;24:995-1011.
15. Glahn D, Reichenberg A, Frangou S, Ormel H. Psychiatricneuroimaging: joining forces with epidemiology. Eur Psychiatry.2008;23:315-319.
16. Cannon TD, van Erp TG, Huttunen M, et al. Regional graymatter, white matter, and cerebrospinal fluid distributions inschizophrenic patients, their siblings, and controls. Arch Gen Psychiatry. 1998;55:1084-1091.
17. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomicalabnormalities before and after onset of psychosis: a crosssectionaland longitudinal MRI comparison. Lancet. 2003;361:281-288.
18. Job DE, Whalley HC, McConnell S, Glabus M, JohnstoneEC, Lawrie SM. Structural gray matter differences betweenfirst-episode schizophrenics and normal controls usingvoxel-based morphometry. Neuroimage. 2002;17:880-889.
19. Whitford TJ, Farrow TF, Gomes L, Brennan J, Harris AW, Williams LM. Grey matter deficits and symptom profilein first episode schizophrenia. Psychiatry Res. 2005;139:229-238.
20. Whitford TJ, Grieve SM, Farrow TF, et al. Progressive greymatter atrophy over the first 2-3 years of illness in firstepisodeschizophrenia: a tensor-based morphometry study.Neuroimage. 2006;32:511-519.
21. Chua SE, Cheung C, Cheung V, et al. Cerebral grey, whitematter and csf in never-medicated, first-episode schizophrenia.Schizophr Res. 2007;89:12-21.
22. Cannon TD, van Erp TG, Rosso IM, et al. Fetal hypoxia andstructural brain abnormalities in schizophrenic patients, theirsiblings, and controls. Arch Gen Psychiatry. 2002;59:35-41.
23. Ridler K, Veijola JM, Tanskanen P, et al. Fronto-cerebellarsystems are associated with infant motor and adult executivefunctions in healthy adults but not in schizophrenia. ProcNatl Acad Sci U S A. 2006;103:15651-15656.
24. Cahn W, Hulshoff Pol HE, Lems EB, et al. Brain volumechanges in first-episode schizophrenia. Arch Gen Psychiatry.2002;59:1002-1010.
25. DeLisi LE, Sakuma M, Maurizio AM, Relja M, Hoff AL.Cerebral ventricular change over the first 10 years after theonset of schizophrenia. Psychiatry Res. 2004;130:57-70.
26. Farrow TF, Whitford TJ, Williams LM, Gomes L, Harris AW. Diagnosis-related regional gray matter loss over twoyears in first episode schizophrenia and bipolar disorder.Biol Psychiatry. 2005;58:713-723.
27. van Haren N, Hulshoff Pol HE, Schnack H, et al. Focal graymatter changes in schizophrenia across the course of theillness: a 5-year follow-up study. Neuropsycho pharmacology.2007;32:2057-2066.
28. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities andtheir relationship to clinical outcome: a longitudinal magneticresonance imaging study early in schizophrenia. Arch Gen Psychiatry. 2003;60:585-594.
29. Hulshoff Pol HE, Kahn RS. What happens after the firstepisode? A review of progressive brain changes in chronicallyill patients with schizophrenia. Schizophr Bull. 2008;34:354-366.
30. Premkumar P, Kumari V, Corr PJ, Sharma T. Frontal lobevolumes in schizophrenia: effects of stage and duration of illness.J Psychiatr Res. 2006;40:627-637.
31. Velakoulis D, Wood SJ, Smith DJ, et al. Increased durationof illness is associated with reduced volume in right medialtemporal/anterior cingulate grey matter in patients withchronic schizophrenia. Schizophr Res. 2002;57:43-49.
32. Rantakallio P. Groups at risk in low birth weight infants andperinatal mortality. Acta Paediatr Scand Suppl. 1969;193:1-71.
33. Rantakallio P. The longitudinal study of the NorthernFinland birth cohort 1966. Paediatr Perinat Epidemiol. 1988;2:59-88.
34. Isohanni M, Miettunen J, Mäki P, et al. Risk factors forschizophrenia. Follow-up data from the Northern Finland1966 Birth Cohort Study. World Psychiatry. 2006;5:168-171.
35. Tanskanen P, Veijola JM, Piippo UK, et al. Hippocampusand amygdala volumes in schizophrenia and other psychosesin the Northern Finland 1966 birth cohort. Schizophr Res.2005;75:283-294.
36. Isohanni M, MäkikyröT, Moring J, et al. A comparison of clinical and research DSM-III-R diagnoses of schizophreniain a Finnish national birth cohort. Clinical and research diagnosesof schizophrenia. Soc Psychiatry Psychiatr Epidemiol.1997;32:303-308.
37. Moilanen K, Veijola J, Läksy K, et al. Reasons for the diagnosticdiscordance between clinicians and researchers inschizophrenia in the Northern Finland 1966 Birth Cohort.Soc Psychiatry Psychiatr Epidemiol. 2003;38:305-310.
38. Räsänen S, Veijola J, Hakko H, Joukamaa M, Isohanni M.Gender differences in incidence and age at onset of DSM-III-R schizophrenia. Preliminary results of the NorthernFinland 1966 birth cohort study. Schizophr Res. 1999;37:197-198.
39. Brammer MJ, Bullmore ET, Simmons A, et al. Generic brainactivation mapping in functional magnetic resonance imaging:a nonparametric approach. Magn Reson Imaging. 1997;15:763-770.
40. Suckling J, Sigmundsson T, Greenwood K, Bullmore ET. Amodified fuzzy clustering algorithm for operator independentbrain tissue classification of dual echo MR images. Magn Reson Imaging. 1999;17:1065-1076.
41. Suckling J, Brammer MJ, Lingford-Hughes A, Bullmore ET.Removal of extracerebral tissues in dual-echo magnetic resonanceimages via linear scale-space features. Magn Reson Imaging.1999;17:247-256.
42. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of theHuman Brain. New York, NY: Thieme Medical Publishers;1988.
43. Jenkinson M, Smith S. A global optimisation method for robustaffine registration of brain images. Med Image Anal.2001;5:143-156.
44. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimizationfor the robust and accurate linear registration and motioncorrection of brain images. Neuroimage. 2002;17:825-841.
45. Lancaster JL, Tordesillas-Gutiérrez D, Martinez M, et al.Bias between MNI and Talairach coordinates analyzed usingthe ICBM-152 brain template. Hum Brain Mapp. 2007;28:1194-1205.
46. Bullmore ET, Brammer MJ, Rouleau G, et al. Computerizedbrain tissue classification of magnetic resonance images:a new approach to the problem of partial volume artefact.Neuroimage. 1995;2:133-147.
47. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ. Global, voxel, and cluster tests, bytheory and permutation, for a difference between two groupsof structural MR images of the brain. IEEE Trans Med Imaging.1999;18:32-42.
48. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia:an anatomical likelihood estimation meta-analysis.Am J Psychiatry. 2008;165:1015-1023.
49. Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, McGuire PK. Mapping of grey matter changes in schizophrenia.Schizophr Res. 1999;35:1-14.
50. Suzuki M, Nohara S, Hagino H, et al. Regional changes inbrain gray and white matter in patients with schizophreniademonstrated with voxel-based analysis of MRI. Schizophr Res. 2002;55:41-54.
51. Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. Anterior cingulate volumes in schizophrenia:a systematic review and a meta-analysis of MRI studies.Schizophr Res. 2007;93:1-12.
52. Chudasama Y, Robbins TW. Functions of frontostriatal systemsin cognition: comparative neuropsychopharmacologicalstudies in rats, monkeys and humans. Biol Psychol. 2006;73:19-38.
53. Mohanty A, Engels AS, Herrington JD, et al. Differential engagementof anterior cingulate cortex subdivisions for cognitiveand emotional function. Psychophysiology. 2007;44:343-351.
54. Kopelman A, Andreasen NC, Nopoulos P. Morphology of the anterior cingulate gyrus in patients with schizophrenia: relationshipto typical neuroleptic exposure. Am J Psychiatry.2005;162:1872-1878.
55. McCormick L, Decker L, Nopoulos P, Ho B-C, Andreasen N.Effects of atypical and typical neuroleptics on anterior cingulatevolume in schizophrenia. Schizophr Res. 2005;80:73-84.
56. Paus T, Otaky N, Caramanos Z, et al. In vivo morphometryof the intrasulcal gray matter in the human cingulate, paracingulate, and superior-rostra1 sulci: hemispheric asymmetries, gender differences and probability maps. J Comp Neurol. 1996;376:664-673.
57. Yücel M, Stuart GW, Maruff P, et al. Paracingulate morphologicdifferences in males with established schizophrenia:a magnetic resonance imaging morphometric study. Biol Psychiatry.2002;52:15-23.
58. Fornito A, Whittle S, Wood SJ, Velakoulis D, Pantelis C, Yücel M. The influence of sulcal variability on morphometryof the human anterior cingulate and paracingulate cortex.Neuroimage. 2006;33:843-854.
59. Gaser C, Volz H-P, Kiebel S, Riehemann S, Sauer H. Detectingstructural changes in whole brain based on nonlineardeformations-applications to schizophrenia research. Neuroimage.1999;10:107-113.
60. Andreasen NC. A unitary model of schizophrenia: Bleuler's''fragmented phrene'' as schizencephaly. Arch Gen Psychiatry.1999;56:781-787.
61. Schmahmann JD. From movement to thought: anatomic substratesof the cerebellar contribution to cognitive processing.Hum Brain Mapp. 1996;4:174-198.
62. Wassink TH, Andreasen NC, Nopoulos P, Flaum M. Cerebellarmorphology as a predictor of symptom and psychosocialoutcome in schizophrenia. Biol Psychiatry. 1999;45:41-48.
63. Marcelis M, Suckling J, Woodruff P, Hofman P, Bullmore E, van Os J. Searching for a structural endophenotype in psychosisusing computational morphometry. Psychiatry Res.2003;122:153-167.
64. Konick LC, Friedman L. Meta-analysis of thalamic size inschizophrenia. Biol Psychiatry. 2001;49:28-38.
65. Chakos MH, Lieberman JA, Bilder RM, et al. Increase in caudatenuclei volumes of first-episode schizophrenic patients takingantipsychotic drugs. Am J Psychiatry. 1994;151:1430-1436.
66. Chakos MH, Shirakawa O, Lieberman J, Lee H, Bilder R, Tamminga CA. Striatal enlargement in rats chronically treatedwith neuroleptic. Biol Psychiatry. 1998;44:675-684.
67. Corson PW, Nopoulos P, Miller DD, Arndt S, AndreasenNC. Change in basal ganglia volume over 2 years in patientswith schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry. 1999;156:1200-1204.
68. Whitforth AB, Kemmler G, Honeder M, et al. Longitudinalvolumetric MRI study in first- and multiple-episode maleschizophrenia patients. Psychiatry Res. 2005;140:225-237.
69. Whitford TJ, Grieve SM, Farrow TF, et al. Volumetric whitematter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry.2007;164:1082-1089.
70. Pantelis C, Yucel M, Wood SJ, et al. Structural brain imagingevidence for multiple pathological processes at differentstages of brain development in schizophrenia. Schizophr Bull. 2005;31:672-696.
71. Woods BT. Is schizophrenia a progressive neurodevelopmentaldisorder? Toward a unitary pathogenic mechanism. Am J Psychiatry. 1998;155:1661-1670.
72. Woods BT, Ward KE, Johnson EH. Meta-analysis of the timecourseof brain volume reduction in schizophrenia: implicationsfor pathogenesis and early treatment. Schizophr Res. 2005;73:221-228.
73. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychoticmedications on brain size before and after tissue fixation:a comparison of haloperidol and olanzapine in macaque monkeys.Neuropsycho pharmacology. 2005;30:1649-1661.
74. Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA. Effect of chronic exposure to antipsychoticmedication on cell numbers in the parietal cortex of macaquemonkeys. Neuropsycho pharmacology. 2007;32:1216-1223.
75. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychoticdrug effects on brain morphology in first-episode psychosis.Arch Gen Psychiatry. 2005;62:361-370.
76. Cannon TD, Hennah W, van Erp TG, et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontalgray matter, and impaired short- and long-term memory.Arch Gen Psychiatry. 2005;62:1205-1213.
77. van Erp TG, Saleh PA, Rosso IM, et al. Contributions of geneticrisk and fetal hypoxia to hippocampal volume inpatients with schizophrenia or schizoaffective disorder, theirunaffected siblings, and healthy unrelated volunteers. Am J Psychiatry. 2002;159:1514-1520.
78. van Erp TG, Saleh PA, Huttunen M, et al. Hippocampal volumesin schizophrenic twins. Arch Gen Psychiatry. 2004;61:346-353.
79. Hulshoff Pol HE, Schnack HG, Bertens MG, et al. Volumechanges in gray matter in patients with schizophrenia. Am J Psychiatry. 2002;159:244-250.
80. Barnett JH, Werners U, Secher SM, et al. Substance use ina population-based clinic sample of people with first-episodepsychosis. Br J Psychiatry. 2007;190:515-520.
81. Schlaepfer TE, Lancaster E, Heidbreder R, et al. Decreasedfrontal white-matter volume in chronic substance abuse. IntJ Neuropsychopharmacol. 2006;9:147-153.
82. Rais M, Cahn W, Van Haren N, et al. Excessive brain volumeloss over time in cannabis-using first-episode schizophreniapatients. Am J Psychiatry. 2008;165:490-496.
83. Welham J, Isohanni M, Jones P, McGrath J. The antecedentsof schizophrenia: a review of birth cohort studies.[published online ahead of print July 24, 2008]. Schizophr Bull. doi:10.1093/schbul/sbn084.